Clinical Study of Cord Blood Mononuclear Cells on Treatment of Hormone-resistant or Hormone-dependent Ulcerative Colitis
Status:
Recruiting
Trial end date:
2022-12-31
Target enrollment:
Participant gender:
Summary
This study conducted a systematic clinical observation of the clinical efficacy of UCB-MNCs
in the treatment of hormone-resistant or hormone-dependent ulcerative colitis, in order to
observe its clinical safety and efficacy.